|

Renin-angiotensin-aldosterone system inhibitors Clinical Trials

1 actively recruiting trial

Also known as: Angiotensin II receptor blockers (ARBs), Angiotensin-converting enzyme (ACE) inhibitors

Pipeline

Phase 4: 1

Top Sponsors

  • National Heart Centre Singapore1

Indications

  • Diabetes Mellitus1
  • Cardiovascular Diseases1
  • Diabetes1

Other1 trial

Asian Diabetes Outcomes Prevention Trial
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.